José Angel Martínez Escribano

Title: José Angel Martínez Escribano: Innovator in Vaccine Development

Introduction

José Angel Martínez Escribano is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development, particularly in the area of rotavirus infections. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

His latest patents include innovative approaches to combat rotavirus infections. One patent focuses on a monomeric VHH domain derived from anti-VP6 camelid antibodies, which includes a dimeric domain, immunization method, and treatment methods for rotavirus infections. This invention specifically targets the protein VP6 of Group A rotavirus, utilizing amino acid sequences that enhance its efficacy. Another patent involves a fusion protein designed to direct vaccine antigens to antigen-presenting cells. This gene construct comprises nucleotide sequences that encode a polypeptide with a region recognizing the β chain of the class-II DR antigen on antigen-presenting cells, along with a vaccinal antigen of interest.

Career Highlights

Throughout his career, José has worked with esteemed organizations such as the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria and Alternative Gene Expression, S.L. His experience in these institutions has allowed him to develop and refine his innovative ideas in vaccine technology.

Collaborations

José has collaborated with notable professionals in his field, including Andrés Wigdorovitz and Félix Gil Dones. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

José Angel Martínez Escribano is a prominent figure in the realm of vaccine innovation, with a focus on addressing rotavirus infections. His patents reflect a commitment to improving public health through scientific advancements.